Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




CT Radiomics Helps Classify Small Lung Nodules

By HospiMedica International staff writers
Posted on 01 Feb 2021
A machine-learning (ML) algorithm can be highly accurate for classifying very small lung nodules found in low-dose CT lung screening programs, according to a new study.

Researchers at the BC Cancer Research Center (BCCRC; Vancouver, Canada) trained a linear discriminant analysis (LDA) ML algorithm--using data from the Pan-Canadian Early Detection of Lung Cancer (PanCan) study--to characterize, analyze, and classify small lung nodules as malignant or benign by extracting approximately 170 texture and shape radiomic features, following semi-automated nodule segmentation on the images. More...
They then compared the performance of the algorithm with that of the Prostate, Lung, Colorectal, and Ovarian (PLCO) m2012 malignancy risk score calculator on another dataset.

The study cohort consisted of 139 malignant nodules and 472 benign nodules that were approximately matched in size. The researchers applied size restrictions (based on Lung-RADS classification criteria) to remove any nodules from the dataset that would already be considered suspicious, which would include any nodule with solid components greater than 8 mm in diameter. The results showed the ML algorithm significantly outperformed the (PLCO) m2012 risk-prediction model, especially when demographic data were added to radiomics analysis. The study was presented at the AACR Virtual Special Conference on Artificial Intelligence, Diagnosis, and Imaging, held during January 2021.

“The best results were achieved in a subset of patients who were younger than 64, female, did not have emphysema, smoked fewer than 42 pack years, did not have a family history of lung cancer, and were not current smokers,” said senior author and study presenter Rohan Abraham, PhD. “Combined with clinician expertise and experience, this has the potential to enable earlier intervention and reduce the need for follow-up CT.”

Current lung nodule classification relies on nodule size, a factor that is of limited use for sub-centimeter nodules, or on volume doubling time, a variable that requires follow-up CT exams. As a result, very small lung nodules, with solid components of less than 8 mm in diameter (and therefore below the Lung-RADS 4A risk-stratification threshold), are very difficult to classify, and they are often given a "wait and see" management plan.

Related Links:
BC Cancer Research Center


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.